3a,16-Dihydroxyandrostenone
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
m |
|||
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | |||
- | |||
<table align='right' border=1> | <table align='right' border=1> | ||
<tr><td> | <tr><td> | ||
Line 12: | Line 10: | ||
</td></tr></table> | </td></tr></table> | ||
==Description== | ==Description== | ||
+ | [http://172.141.127.22/raghava/hmrbase/test_extract.php?db=arun&table=nphormonet&id=1127&show=SHOW-3D Show 3-D Structure] | ||
+ | |||
3a,16-Dihydroxyandrostenone is a urinary C19 steroid usually present in very low level in normal pregnancy; however, it is increased in women with androgenic alopecia (PMID 10751586) and in a patient who developed virilizing luteoma during the 8th month of pregnancy (PMID 14004108) | 3a,16-Dihydroxyandrostenone is a urinary C19 steroid usually present in very low level in normal pregnancy; however, it is increased in women with androgenic alopecia (PMID 10751586) and in a patient who developed virilizing luteoma during the 8th month of pregnancy (PMID 14004108) | ||
==General Properties== | ==General Properties== | ||
Line 54: | Line 54: | ||
- | [[ | + | [[Category:Hormones]] |
+ | [[Category:HMRbase]] |
Current revision
|
Contents |
[edit] Description
3a,16-Dihydroxyandrostenone is a urinary C19 steroid usually present in very low level in normal pregnancy; however, it is increased in women with androgenic alopecia (PMID 10751586) and in a patient who developed virilizing luteoma during the 8th month of pregnancy (PMID 14004108)
[edit] General Properties
*Molecular Weight
304.42
*Molecular Formula
C19H28O3
*IUPAC NAME
(3a)-3,16-dihydroxy-Androst-5-en-17-one
*Canonical Smiles
CC12CCC3C(CCC4CC(O)=CC(=O)C34C)C1CC(O)C2
*Isomeric Smiles
C[C@]12CC[C@H]3[C@@H](CCC4CC(O)=CC(=O)[C@]34C)[C@@H]1CC(O)C2
[edit] PhysioChemical Properties
*Melting Point
*LogP
*Water Solubility
[edit] External Links
- [1]Human Metabolome DataBase